USA - New York Stock Exchange - NYSE:WST - US9553061055 - Common Stock
We assign a fundamental rating of 7 out of 10 to WST. WST was compared to 57 industry peers in the Life Sciences Tools & Services industry. WST scores excellent points on both the profitability and health parts. This is a solid base for a good stock. WST is not valued too expensively and it also shows a decent growth rate. These ratings could make WST a good candidate for quality investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.98% | ||
| ROE | 16.11% | ||
| ROIC | 14.78% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.71% | ||
| PM (TTM) | 16.29% | ||
| GM | 35.58% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 13.18 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 2.18 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.47 | ||
| Fwd PE | 30.15 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.91 | ||
| EV/EBITDA | 22.03 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
ChartMill assigns a fundamental rating of 7 / 10 to WST.
ChartMill assigns a valuation rating of 4 / 10 to WEST PHARMACEUTICAL SERVICES (WST). This can be considered as Fairly Valued.
WEST PHARMACEUTICAL SERVICES (WST) has a profitability rating of 8 / 10.
The financial health rating of WEST PHARMACEUTICAL SERVICES (WST) is 8 / 10.
The dividend rating of WEST PHARMACEUTICAL SERVICES (WST) is 6 / 10 and the dividend payout ratio is 12.34%.